CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 25 enrolled
Drug / intervention
Tranexamic Aciddrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02867163
NCT02867163N/ACompleted
CompareCT.gov

Does the Intraoperative Administration of Tranexamic Acid (TXA) Increase the Incidence of Deep Venous Thrombosis in Total Knee Arthroplasty?

University of New Mexico·observational·Posted Aug 15, 2016·Updated May 20, 2019

In Brief

An observational study evaluating Tranexamic Acid for Venous Thrombosis. Completed, enrolled 25 participants across 1 site.

Detailed Summary

This is an observational trial to estimate the incidence of deep vein thrombosis (DVT) in total knee replacement patients who received an intraoperative dose of tranexamic acid.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsVenous Thrombosis
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedAug 15, 2016
Enrollment StartMay 16, 2017
Primary CompletionNov 8, 2017
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 9.9 years ago

Interventions

Tranexamic Aciddrug

Intravenous or local administration of TXA, in any dosage